DM
BLUE

Deerfield Management’s bluebird bio BLUE Stock Holding History

Deerfield Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-108,750
Closed -$6.92M – 102
2023
Q1 		$6.92M Buy
+108,750
New +$12.4M 0.15% 78
2021
Q3 		– Sell
-37,079
Closed -$15.4M – 137
2021
Q2 		$15.4M Hold
37,079
– – 0.27% 93
2021
Q1 		$14.5M Buy
+37,079
New +$18.3M 0.3% 86
2018
Q4 		– Sell
-4,743
Closed -$8.97M – 102
2018
Q3 		$8.97M Sell
4,743
-3,981
-46% -$8.22M 0.32% 73
2018
Q2 		$17.7M Buy
8,724
+5,559
+176% +$12.7M 0.62% 60
2018
Q1 		$7M Sell
3,165
-3,011
-49% -$7.66M 0.24% 95
2017
Q4 		$14.2M Buy
+6,176
New +$12.5M 0.56% 56
2017
Q2 		– Sell
-8,265
Closed -$9.73M – 87
2017
Q1 		$9.73M Sell
8,265
-15,051
-65% -$15.4M 0.38% 68
2016
Q4 		$18.6M Buy
23,316
+6,023
+35% +$4.78M 0.77% 42
2016
Q3 		$15.2M Sell
17,293
-8,807
-34% -$6.38M 0.71% 41
2016
Q2 		$14.6M Buy
+26,100
New +$14.8M 0.58% 52
2015
Q4 		– Sell
-37,288
Closed -$41.3M – 113
2015
Q3 		$41.3M Buy
37,288
+12,060
+48% +$22M 1.6% 17
2015
Q2 		$55M Sell
25,228
-23,509
-48% -$47.9M 1.83% 12
2015
Q1 		$76.2M Sell
48,737
-16,955
-26% -$22.4M 2.47% 9
2014
Q4 		$78M Sell
65,692
-31,479
-32% -$21M 2.8% 9
2014
Q3 		$45.2M Buy
97,171
+14,160
+17% +$6.53M 1.65% 20
2014
Q2 		$41.5M Buy
83,011
+51,014
+159% +$16.4M 1.67% 18
2014
Q1 		$9.43M Sell
31,997
-676
-2% -$205K 0.38% 68
2013
Q4 		$8.88M Hold
32,673
– – 0.46% 58
2013
Q3 		$11.4M Buy
+32,673
New +$12.1M 0.53% 61

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deerfield Management's BLUE Position: Q2 2023 in Review

Deerfield Management sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 108,750 shares — an estimated $6.92M sold.

Deerfield Management first reported a position in BLUE in Q3 2013 and held it in 20 quarters. The position peaked at $78M in Q4 2014. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

  • Deerfield Management reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
  • Deerfield Management sold 108,750 bluebird bio shares in Q2 2023, an estimated $6.92M.
  • Deerfield Management first reported a position in bluebird bio in Q3 2013 and held it in 20 quarters.
  • Deerfield Management's bluebird bio position peaked at $78M in Q4 2014.
  • 175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Deerfield Management's 13F filing for Q2 2023, filed 14 Aug 2023.